| 
						France confirms case of 
						mad cow disease 
   Send a link to a friend 
		[March 24, 2016] 
		PARIS (Reuters) - France's 
		agriculture ministry confirmed on Thursday that a case of bovine 
		spongiform encephalopathy (BSE), or mad cow disease, had been discovered 
		in the northeastern region of Ardennes. | 
        
            | 
			
			 The suspected case, found in a five-year-old cow, was identified 
			last week during a test carried out on cattle older than 48 months 
			after slaughter. 
 The farm ministry said there was no risk to human health as all 
			parts of the cow susceptible to being infected must be removed by 
			slaughter houses.
 
 "The detection of this case does not affect the consumer," it said 
			in a statement. "Beef consumption is safe for humans."
 
 However, the outbreak is likely to affect French exports, the 
			ministry said on its website, because the country's official BSE 
			risk level assigned by the OIE would be changed.
 
			
			 
			"Depending on countries, export conditions of French cattle could be 
			modified," it said.
 Last year France regained the safest BSE rating of "negligible risk" 
			as it was able to demonstrate that the last infected native animal 
			was born more than 11 years ago.
 
 Several countries including South Africa, Saudi Arabia, Vietnam and 
			Singapore lifted embargos on French beef following the OIE decision.
 
 BSE was first detected in Britain in the late 1980s, spreading from 
			there to other parts of Europe and ravaging cattle herds until the 
			early 2000s. It has been linked to the brain-wasting 
			Creutzfeldt-Jakob disease in humans.
 
			
            [to top of second column] | 
 
			The latest case in France did not point to any rebound in the 
			disease, the OIE said.
 OIE data showed just six cases of BSE worldwide in 2015, of which 
			four were in the EU. That was down from 1,957 in 2000, 561 in 2005 
			and 125 in 2008.
 
 "The risk management and monitoring systems set up in the early 
			2000s have shown their effectiveness considering the drastic 
			reduction of cases," an OIE spokeswoman said.
 
 (Reporting by Sybille de La Hamaide; editing by Jason Neely)
 
			[© 2016 Thomson Reuters. All rights 
				reserved.] Copyright 2016 Reuters. All rights reserved. This material may not be published, 
			broadcast, rewritten or redistributed. 
			
			 
			
			 |